Alternativa al tratamiento quirúrgico en el carcinoma basocelular en la población anciana: imiquimod 5% crema
Tài liệu tham khảo
Buendia Eisman, 2002, Epidemiología del cáncer cutáneo no melanoma, Piel, 17, 3, 10.1016/S0213-9251(02)72523-9
Oldfield, 2005, Imiquimod: in superficial basal cell carcinoma, Am J Clin Dermatol, 6, 195, 10.2165/00128071-200506030-00006
Beutner, 1999, Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream, J Am Acad Dermatol, 41, 1002, 10.1016/S0190-9622(99)70261-6
Schulze, 2005, Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe, Br J Dermatol, 152, 939, 10.1111/j.1365-2133.2005.06486.x
Burkhardt Pérez, 2007, Basal cell carcinoma: Treatment with imiquimod, Int J Dermatol, 46, 539, 10.1111/j.1365-4632.2007.03230.x
Ezughah, 2008, A randomized parallel study to assess the safety and efficacy of two different dosing regimens of 5% imiquimod in the treatment of superficial basal cell carcinoma, J Dermatolog Treat, 19, 111, 10.1080/09546630701557965
Quirk, 2006, Two-year interim results from a 5-year study evaluating clinical recurrence of superficial basal cell carcinoma after treatment with imiquimod 5% cream daily for 6 weeks, Australas J Dermatol, 47, 258, 10.1111/j.1440-0960.2006.00313.x
Rodríguez Caravaca, 1998, Validez del diagnóstico clínico del carcinoma basocelular, Piel, 6, 273